 |
인쇄하기
취소
|
Exforge gets U.S. approval, Novartis says
Published: 2007-01-17 07:00:00
Updated: 2007-01-17 07:00:00
Swiss drugmaker Novartis AG said its Exforge antihypertensive medication has recently received approval from the U.S. Food and Drug Administration (FDA).
Exforge combines valsartan and amlodipine besylate in one pill.
"Exforge is expected to be available to patients in the U.S. in late September 2007, pending the expiration of market exclusivity and patent protection for amlodipine besyl...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.